Investment Rating - The report maintains a "Buy" rating for the company [5]. Core Insights - The company reported a total net revenue of 4.4 billion yuan for the fiscal year 2025, a year-on-year decline of 32.7%, but achieved a net profit of 6.19 million yuan, recovering from losses in the first half of the fiscal year [1]. - The company's self-operated product strategy has matured, becoming a core growth engine, with self-operated product GMV reaching approximately 3.81 billion yuan, accounting for 43.8% of total GMV [2]. - The self-built APP channel has shown steady growth, with APP revenue of about 1.1 billion yuan, representing a year-on-year increase of 22% and accounting for 25% of total revenue [3]. - The company has adjusted its profit forecasts for fiscal years 2026 and 2027, reducing the expected net profit to 270 million yuan and 340 million yuan respectively, while introducing a new forecast for fiscal year 2028 at 400 million yuan [4]. Summary by Sections Financial Performance - For fiscal year 2025, the company reported a total net revenue of 4.4 billion yuan, a decrease of 32.7% year-on-year, while the net profit from continuing operations was 6.19 million yuan, down 97.5% year-on-year [1]. - The self-operated product GMV was approximately 3.81 billion yuan, which is 43.8% of total GMV, and the self-operated product revenue was about 3.5 billion yuan, making up 80% of total revenue [2]. APP Development and Membership Growth - The self-built APP channel achieved revenue of approximately 1.1 billion yuan, a 22% increase year-on-year, and accounted for 25% of total revenue [3]. - The number of paid APP members reached 264,000, reflecting a growth of 33% year-on-year, with a user satisfaction rate of 98.7% [3]. Profit Forecast and Valuation - The company has adjusted its profit forecasts for fiscal years 2026 and 2027, with expected net profits of 270 million yuan and 340 million yuan respectively, and a new forecast for fiscal year 2028 at 400 million yuan [4].

Core Insights - The Hong Kong stock market saw significant net inflows from northbound capital, totaling HKD 165.73 billion on August 26, with the Shanghai-Hong Kong Stock Connect contributing HKD 96.05 billion and the Shenzhen-Hong Kong Stock Connect contributing HKD 69.67 billion [1] Group 1: Stock Performance - The most net bought stocks included the Tracker Fund of Hong Kong (02800), Hang Seng China Enterprises (02828), and Alibaba-W (09988) [1][5] - The most net sold stocks were SMIC (00981), Oriental Selection (01797), and Xiaomi Group-W (01810) [1][5] - The Tracker Fund of Hong Kong received a net inflow of HKD 50.04 billion, while SMIC experienced a net outflow of HKD 15.76 billion [2][3] Group 2: Sector Trends - Technology stocks, particularly Alibaba-W, Tencent (00700), and Meituan-W (03690), saw substantial net purchases of HKD 13.45 billion, HKD 6.7 billion, and HKD 4.09 billion respectively [5] - The approval of new regulations for internet platform pricing is expected to lead to more standardized pricing practices among e-commerce platforms, which may help maintain market shares [5] - The biotechnology sector is highlighted by the net purchase of HKD 1.25 billion in Innovent Biologics (01801), following the FDA's approval of a new drug trial [6] Group 3: Company-Specific Developments - Meituan (01357) was included in the MSCI China Index, which is expected to enhance its market visibility and investment appeal [5] - Xiaomi Group-W reported a 40% year-on-year increase in automotive revenue, although its smartphone business faced challenges with declining margins [7] - Oriental Selection's performance was mixed, with a 55% year-on-year drop in GMV, leading to a downgrade in its target price by Goldman Sachs [7]

罗永浩回应网友喊话邀请俞敏洪、王自如 近日，罗永浩官宣播客节目《罗永浩的十字路口》，并在第一期邀请了理想汽车创始人李想。评论区，有网友喊话罗永浩邀请俞敏洪、王自如上节目。罗 永浩先后回复："已拉黑""也已拉黑"。 随后罗永浩还辟谣"拉黑俞敏洪王自如"称，只是把起哄的网友拉黑。 | | | 东方甄选[01797] 2025-08-26 16:00 | | | 5PMA = | | 10PMA = 20PMA = 30PMA = | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 58.343 | | | | | | | | | | 51.870 | | | | | | | | | | 45.396 | | | | | | | | | | 38.923 | | | | | | | | | | 32.450 | | | | | | | | | | 25.977 | | | | | | | | | | 19.504 | | | | | | | | | | 13.030 | | | | | | | | | | 6.557 | | | | | | | ...

中国经济网北京8月26日讯 东方甄选（01797.HK）港股今日收报28.08港元，跌幅11.20%。 （责任编辑：魏京婷） ...

| 指数 | 最新 | 涨跌幅 | | --- | --- | --- | | 相生指数 | 25524.92 | -1.18% | | 国企指数 | 9148.66 | -1.07% | | 红筹指数 | 4343.85 | -1.02% | 免责声明：本文内容与数据仅供参考，不构成投资建议，使用前请核实。据此操作，风险自担。 每经AI快讯：北京时间8月26日16:00，恒生指数收盘下跌304.99点，跌幅为1.18%，报收25524.92点；国 企指数收盘下跌99.34点，跌幅为1.07%，报收9148.66点；红筹指数收盘下跌44.65点，跌幅为1.02%，报 收4343.85点。南向资金当日净流入165.73亿港元。东方甄选跌超11%，蔚来、君实生物跌超6%，中兴 通讯跌近6%，碧桂园跌超5%；中国黄金国际涨超10%，灵宝黄金涨超9%。 （记者 胡玲） ...

责任编辑：杨红卜 炒股就看金麒麟分析师研报，权威，专业，及时，全面，助您挖掘潜力主题机会！ 8月26日，港股收盘，恒生指数跌1.18%，恒生科技指数跌0.74%。东方甄选跌超11%，蔚来、君实生物 跌超6%，中兴通讯跌近6%，碧桂园跌超5%；中国黄金国际涨超10%，灵宝黄金涨超9%。 ...

Core Viewpoint - Oriental Selection (1797.HK) experienced a significant intraday drop of nearly 11%, trading at 28.2 HKD, with a transaction volume exceeding 22 billion HKD [1] Financial Performance - For the fiscal year 2025 (June 2024 - May 2025), the net revenue from the continuing operations (self-operated products and live e-commerce) decreased by 32.7% year-on-year from 6.5 billion to 4.4 billion HKD [1] - The net profit from continuing operations was 6.191 million HKD, a substantial decline of 97.5% compared to 249 million HKD in the same period last year [1] Market Analysis - Goldman Sachs reported that Oriental Selection's performance for the second half of the fiscal year ending in May showed mixed results, with the gross merchandise volume (GMV) dropping by 55% year-on-year to 3.9 billion HKD, which was 15% lower than the bank's expectations [1]

记者丨刘雪莹 罗永浩回应网友喊话邀请俞敏洪、王自如 近日，罗永浩官宣播客节目《罗永浩的十字路口》，并在第一期邀请了理想汽车创始人李想。评论区， 有网友喊话罗永浩邀请俞敏洪、王自如上节目。罗永浩先后回复："已拉黑""也已拉黑"。 随后罗永浩还辟谣"拉黑俞敏洪王自如"称，只是把起哄的网友拉黑。 编辑丨陈思颖 8月26日午后，港股东方甄选跌近11%，成交额超20亿元。 据智通财经报道，高盛就东方甄选发布研报称，下调公司2026至2027财年GMV预测1%至3%，受益于自 营品牌产品GMV贡献提升，将收入预测上调最多10%，2026至2027财年经调整净利润率预测上调0.2% 和1%，目标价上调至9港元。因基本面持续疲软，加上估值较贵，该行维持沽售评级。 | 1 FEBRT FREEKS | 要会議:已拉爾维數以下自由 | | --- | --- | | | Sach直接的月26日消费, 最新机制度, OT | | 日本の原因的に行ける。 (0)年度は10000) | 永进的十零曲口 直文集团:"我们第一期修落 | | 和相关服务器价值得非值税处 | 可群上线图:24小时全网设组+角组织建设管 | | | 服は200 ...

Group 1 - The core viewpoint of the article highlights a significant decline in the financial performance of Dongfang Zhenxuan (1797.HK), with a nearly 11% drop in stock price and a trading volume exceeding 22 billion HKD [1][3]. - For the fiscal year 2025 (June 2024 - May 2025), the net revenue from ongoing operations (self-operated products and live e-commerce) decreased by 32.7% year-on-year from 6.5 billion to 4.4 billion CNY, while the net profit plummeted by 97.5% from 249 million to 6.19 million CNY [3]. - Goldman Sachs reported that Dongfang Zhenxuan's performance for the second half of the fiscal year ending in May showed mixed results, with the gross merchandise volume (GMV) declining by 55% year-on-year to 3.9 billion CNY, which was 15% lower than their expectations [3].

Group 1 - Goldman Sachs maintains a sell rating on Dongfang Zhenxuan (01797.HK) and raises the target price to HKD 9, while adjusting the GMV forecast down by 1% to 3% for FY2026-2027 due to weak fundamentals and high valuation [1] - CITIC Securities maintains an outperform rating on Pop Mart (09992.HK) and raises the target price to HKD 368, expecting strong global demand with sales growth of 14%, 12%, and 12% for 2025-2027 [1] - CMB International maintains a buy rating on Kuaishou-W (01024.HK) and raises the target price to HKD 90, citing optimism about its multi-scenario e-commerce strategy and AI commercialization [1] Group 2 - Huazhang Securities maintains a buy rating on Xiaomi Group-W (01810.HK), forecasting revenue growth of RMB 478.1 billion, 618.2 billion, and 732 billion for 2025-2027, with adjusted net profit of RMB 41.1 billion, 59.3 billion, and 72.4 billion [2] - Morgan Stanley maintains an overweight rating on NIO-SW (09866.HK) with a target price of HKD 50.7, noting strong ES8 orders and expected monthly sales of 40,000 to 50,000 vehicles starting in October [3] - CICC maintains an outperform rating on Bruker (00325.HK) with a target price of HKD 135, reporting a 27.9% revenue growth to HKD 1.34 billion for the first half of 2025 [4] Group 3 - Haitong International maintains an outperform rating on Genscript Biotech (01548.HK) with a target price of HKD 24.62, reporting an 81.9% revenue growth to USD 519 million for the first half of 2025 [5] - Cathay Pacific maintains a buy rating on Sunny Optical Technology (02382.HK) with a target price of HKD 108.05, noting a 15% net profit beat and an 18.2% revenue growth in automotive electronics [6] - Cathay Pacific maintains an overweight rating on Baidu Group-SW (09888.HK) with a target price of HKD 104, reporting a 34% increase in non-advertising revenue driven by AI cloud services [8]